試す - 無料

Bio Spectrum - May 2018

filled-star
Bio Spectrum

Magzter GOLDで無制限に

読む Bio Spectrum 9,500以上の雑誌や新聞を1回の定期購読で購読できます  

カタログを見る

1ヶ月

$14.99

1年

$149.99

$12/month

(OR)

Bio Spectrumのみを購読する

この号を購入: May 2018

May 2018 から始まる 1 号

May 2018 から始まる 12 号

この号を購入する

$0.99

1年

$10.99

Please choose your subscription plan

いつでもキャンセルできます。

(義務なし) ⓘ

定期購読にご満足いただけない場合は、定期購読開始日から 7 日以内に help@magzter.com までメールをお送りいただければ、全額返金いたします。質問は一切ありません。お約束します! (注: 単号購入には適用されません)

デジタルサブスクリプション

即時アクセス ⓘ

今すぐ購読すると、Magzter の Web サイト、iOS、Android、Amazon アプリですぐに読み始めることができます。

安全性を確認済み

支払い ⓘ

Magzter は Authorize.Net の認定販売業者です。詳細はこちら

この号では

ADDRESSING THE INDUSTRY ACADEMIA GAP

India has been witnessing a good growth in economic and industrial development, which leads to increasing needs on education and calls for a highly diversified human resource. India is many paradigm shifts in the social, business and industrial environment. The onus of making available the skilled human resource lies on system of higher education.
The evolving science in the biotech sector is leading to a demand for high-skilled jobs in India. However, a wide gap currently exists between the quality of human capital available and the needs of the industry. To address this talent defi cit by developing Industry ready human capital for the Biopharma sector and enable global competitiveness of the sector, Dr Manbeena Chawla of BioSpectrum spoke to the captains and HR heads of few leading companies on what the industry needs from the academia and how these companies are addressing the gap of talent and skills sets.
Besides we will be covering the leading biotech, life sciences, and pharmaceutical companies like Dr Reddy’s Labs, Biocon, Cadila Pharmaceucails, Reliance Life Sciences who have set up academy, institutes with an aim to support the industry with skilled manpower and workforce and bridge the gap between industry and academia

Bio Spectrum Description:

India's leading publication that covers the business of bio-technology. With comprehensive analyses of policy issues, products and services across the bio-pharma, bio-informatics, bio-infrastructure and bio-agriculture segments, it is the industry's most authoritative source of information.

最近の問題

  • March 2013

    March 2013

関連タイトル

人気カテゴリー